Evidence map›Paper›PMID 35493755›Full record

ArticleVirusdisease2022

Glutathione reductase system changes in HTLV-1 infected patients.

Sajad Ehtiati, Masoud Youssefi, Houshang Rafatpanah, Baratali Mashkani, Majid Khadem-Rezaiyan, Farnaz Zahedi Avval

Open access · greenAbstract read
In one paragraph

Article in Virusdisease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sajad EhtiatiDepartment of Clinical Biochemistry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, 917794-8564 Iran.
Masoud YoussefiDepartment of Microbiology and Virology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID 0000-0001-6028-3573
Houshang RafatpanahDepartment of Immunology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID 0000-0002-1061-5864
Baratali MashkaniDepartment of Clinical Biochemistry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, 917794-8564 Iran.ORCID 0000-0002-7606-5455
Majid Khadem-RezaiyanDepartment of Community Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Farnaz Zahedi AvvalDepartment of Clinical Biochemistry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, 917794-8564 Iran.ORCID 0000-0001-8915-3596
Mashhad University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During chronic HTLV-1 infections oxidative stress occurs and contributes in viral pathogenesis. Glutaredoxin (Grx) system is one of the most effective antioxidant components. The system maintains the cellular redox and scavenges reactive oxygen species through the function of glutathione reductase (GR) enzyme, NADPH and reduced glutathione (GSH). This study was performed to investigate potential changes in GR gene expression and activity as well as GSH level, and their association with the viral load in HTLV-1 infection. Forty HTLV-1 seropositive patients divided into two groups: asymptomatic carriers (N = 20) and HAM/TSP (N = 20) with the same number of age and sex-matched healthy controls were recruited in this study. GR cellular gene expression and viral load in PBMCs were determined using Real-time PCR Technique. Enzyme activity and GSH level in sera were measured by commercial kits based on manufacturer's provided protocols. GR gene expression and GR enzyme activity, as well as GSH level, were significantly lower in HTLV-1 patients. A negative correlation between viral load and GR gene expression/enzyme activity was observed in HAM/TSP group. Similarly, a negative relationship between viral load and GSH levels was observed in both carrier and HAM/TSP groups. We also found that in profound complicated condition of HTLV-1 infection, HAM/TSP, Grx system components activity was significantly decreased compared to the controls. Such observation was not the case in clinically healthy HTLV-1 carriers. These findings may shed a light on the conditions contributing in pathogenesis of the complications and exacerbation of the disease in the HAM/TSP cases. Supplementary Information: The online version contains supplementary material available at 10.1007/s13337-022-00758-y.

Indexed as

GlutaredoxinGlutathioneGlutathione reductaseHTLV-1Oxidative stress

Identifiers

PMID35493755
PMCPMC9005565
OpenAlexW4220922255

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.